ISSN: 1094-5539

Journal Home

Journal Guideline

Pulmonary Pharmacology and Therapeutics Q2 Unclaimed

Academic Press Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pulmonary Pharmacology and Therapeutics is a journal indexed in SJR in Medicine (miscellaneous) and Biochemistry (medical) with an H index of 78. It has an SJR impact factor of 0,776 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,776.

Pulmonary Pharmacology and Therapeutics focuses its scope in these topics and keywords: cough, asthma, impact, technique, fibrosis, experimental, fq, harmfulness, idiopathic, induced, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Biochemistry (medical) (Q2) Medicine (miscellaneous) (Q2) Pharmacology (medical) (Q2) Pulmonary and Respiratory Medicine (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,776

SJR Impact factor

78

H Index

40

Total Docs (Last Year)

213

Total Docs (3 years)

1825

Total Refs

718

Total Cites (3 years)

208

Citable Docs (3 years)

3.11

Cites/Doc (2 years)

45.63

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Seizure : the journal of the British Epilepsy Association Q2
Genes to Cells Q2
Acta Neurologica Scandinavica Q2
Clinical Rheumatology Q2
Annals of Global Health Q2

Compare this journals

Aims and Scope

Best articles by citations

Evidence for neuropathic processes in chronic cough

Tolerance to the protective effect of salmeterol in mild untreated asthmatics

Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models

Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options

Pharmacologic characteristics of prulifloxacin

Leukotrienes as Mediators of Asthma

WITHDRAWN: Short- and Long-term Reproducibility of Capsaicin Cough Challenge Testing

A conference report. The Second Siena International Conference on animal models of chronic obstructive pulmonary disease

WITHDRAWN: The Inhalers of the Future? A Review of Dry Powder Devices on the Market Today

Sensory regulation of the cough reflex

WITHDRAWN: The Pathobiological Mechanisms of Emphysema Models: What do They Have in Common?

Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells

SHOW MORE ARTICLES

Diagnosis and Treatment of Chronic Cough due to Gastro-esophageal Reflux Disease and Postnasal Drip Syndrome

Experimental models and mechanisms of enhanced coughing

Prulifloxacin: A new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis

Post-nasal drip syndrome - a symptom to be sniffed at?

Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD

Relationship between Cough, Cough Receptor Sensitivity and Asthma in Children

The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD

The Powerful Placebo in Cough Studies?

Discussion on poster presentations

Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema

Effect of salbutamol on smoking related cough

Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction